| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
DUBLIN, Ohio — May 9, 2022— Cardinal Health (NYSE:CAH) and URAC, the nation’s largest independent health care accreditation organization, announced today an agreement to help customers of...
Read more about Cardinal Health announces agreement with URAC
Revenue increased 14% to $44.8 billion GAAP1 operating loss was $97 million due to a non-cash, pre-tax goodwill impairment of $474 million in the Medical segment; GAAP diluted loss per share was $5.05
Read more about Cardinal Health Reports Third Quarter Fiscal 2022 Results
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas, May 3, 2022—(BUSINESS WIRE)—AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have...
Read more about Distributors Agree to Opioid Settlement with Washington State
Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health...
Read more about Cardinal Health honors top clinical laboratory professionals
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange. The company will...
Cardinal Health (NYSE: CAH) today announced plans to build a 574,670 square foot medical distribution center in the Columbus, Ohio area. The new building will integrate automation and technology...
Read more about Cardinal Health expands medical distribution footprint in Ohio
Nearly 600 clinicians participated in a first-of-its-kind global consensus process supported by a grant from Cardinal Health; key findings include recommendation for use of mechanical compression...
The incise drape is the first to feature Avery Dennison's patented BeneHold™ CHG adhesive technology DUBLIN, Ohio, March 17, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched the...
Read more about New Cardinal Health surgical drape helps reduce surgical site contamination risk
46 of 49 Eligible States and Over 90 Percent of Litigating Political Subdivisions Participate CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC),...
Read more about Distributors Approve Opioid Settlement Agreement
Today Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, and Cardinal Health (NYSE: CAH) announced expanded distribution of Cue's professional use and over-the-counter COVID-19...
Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more,...
Read more about Cardinal Health named one of America's Best Large Employers 2022 by Forbes magazine
Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain agility. Kinaxis will enhance Cardinal...
Read more about Cardinal Health partners with Kinaxis to optimize digital supply chain planning
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer...
Read more about Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in the U.S.
Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year. Second quarter GAAP operating loss was...
Read more about Cardinal Health Reports Second Quarter Fiscal 2022 Results
Medically Home today announced a new, $110 million round of funding from strategic investors including Baxter International Inc., Global Medical Response (GMR) and Cardinal Health who will each...
Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting...
Read more about Cardinal Health Provides Medical Segment Fiscal Year 2022 Financial Update
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company...
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)-- AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that the deadline for...
Melbourne (Australia) and Indianapolis, IN (U.S.A.) – 20 December 2021. Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the...
Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S. "WaveMark is among the...
Read more about Cardinal Health's WaveMark™ launches supply automation solution for clinical labs
Kannapolis, NC—Nov. 16, 2021 – Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery...
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings...
Read more about Cardinal Health Reports First Quarter Fiscal 2022 Results
Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part...
Paoli, PA — Cardinal Health Specialty Solutions and Gastrologix, the only gastroenterology (GI)-specific group purchasing organization (GPO) in the United States, working in conjunction with the...
Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today...
Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its launch. In October last year, the...
Read more about Business solutions for the next public health emergency
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an...
Read more about Distributors Announce Settlement With Cherokee Nation
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange. The company will...
DUBLIN, Ohio—Cardinal Health (NYSE: CAH) today launched the Reimbursement Solution—a comprehensive approach designed to help hospitals and health systems minimize their number of claim...
Read more about Cardinal Health reinvents hospital claims remittance with comprehensive approach
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that, under the previously announced proposed settlement agreement and process designed to...
Read more about Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
DUBLIN, OHIO and FLEURUS, BELGIUM – AUGUST 26, 2021 – Cardinal Health (NYSE: CAH) and IRE ELiT (the radiopharmaceutical subsidiary of IRE Group) are working to expand patient access to novel...
DUBLIN, OHIO – August 20, 2021 — Cardinal Health (NYSE: CAH) issued a voluntary Medical Device correction notice on June 16, 2021 for Argyle™ UVC Insertion Tray containing Safety Scalpel...
DUBLIN, OHIO – August 19, 2021 — On August 4, 2021, Cardinal Health (NYSE: CAH) initiated a nationwide recall of approximately 267 million MonojectTM Flush Prefilled Saline Syringes (0.9%...
Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as...
Read more about Cardinal Health announces redemption of outstanding notes
Cardinal Health (NYSE: CAH) announced today that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027....
Read more about Cardinal Health Extends Pharmaceutical Distribution Agreements with CVS Health
Cardinal Health (NYSE: CAH) today reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion. This increase includes the favorable prior year comparison from reduced...
Read more about Cardinal Health reports fourth quarter and full year results for fiscal year 2021
Chronicled and Cardinal Health today announced a partnership to leverage a new blockchain-powered solution on the MediLedger Network to streamline operations across the pharmaceutical supply chain...
Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of...
Read more about Cardinal Health completes sale of Cordis business to Hellman & Friedman
DUBLIN, Ohio–Cardinal Health WaveMark™ Supply Management & Workflow Solutions has released a whitepaper outlining how automated solutions for inventory management can mitigate supply chain...
Read more about Solutions to optimize the healthcare supply chain
CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a...
Read more about Distributors Announce Proposed Opioid Settlement Agreement
CENTRAL ISLIP, N.Y.--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have agreed to pay up to $1.179 billion in a...
Read more about Distributors Reach Opioid Settlement Agreement With New York State
Cardinal Health (NYSE: CAH) today launched two new innovative solutions – Cardinal HealthTM NavixRxTM Compliance Packaging and E-Commerce Storefront – to help independent pharmacies meet...
Read more about Cardinal Health launches NavixRx™ Compliance Packaging and E-Commerce Storefront
Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of trading on the New York Stock Exchange. The...
In response to Ohio Governor Mike DeWine's request that business leaders help increase vaccination rates, four Ohio Managed Care Organizations (MCOs) are partnering with Outcomes™ to leverage...
Read more about Outcomes™ partners with Medicaid plans to help Ohio Medicaid members get vaccinated
Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 3.200% notes due June 2022 that are outstanding as...
Read more about Cardinal Health announces redemption of outstanding notes
Cardinal Health (NYSE: CAH) today reported third-quarter fiscal year 2021 revenue of $39.3 billion, in-line with the third quarter of last year. Third-quarter GAAP operating earnings decreased 16%...
Read more about Cardinal Health reports third-quarter results for fiscal year 2021
Cardinal Health (NYSE: CAH) today launches Outcomes™, a digital ecosystem connecting pharmacists, payers and pharmaceutical companies to mitigate the challenges of medication non-adherence....
Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...
FourKites will serve as innovation partner and central data hub for all Cardinal Health shipments
Read more about FourKites Announces Partnership with Cardinal Health to Build Cognitive Supply Chain
Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer's...
MIAMI — March 8, 2021 — eMed™, a digital health company democratizing healthcare through digital point-of-care solutions, and Cardinal Health (NYSE: CAH), a healthcare distributor, global...
Cardinal Health Specialty Solutions is making important strides in cancer research using real-world evidence (RWE). Research developed by Cardinal Health, published today in the Journal of the...
Read more about New Cardinal Health cancer research study published in JAMA
To help health systems optimize and benchmark progress as they innovate their clinical and operational supply chains, Cardinal Health WaveMark™ Supply Management & Workflow Solutions announced a...
Cardinal Health (NYSE: CAH) today reported second-quarter fiscal year 2021 revenue of $41.5 billion, an increase of 5% from the second quarter of last year. Second-quarter GAAP operating earnings...
Read more about Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
OptiFreight® Logistics, a Cardinal Health (NYSE: CAH) company, announced today the launch of TotalVue™ Analytics — a tool for healthcare supply chain leaders to utilize predictive technology...
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2021 on February 5 prior to the opening of trading on the New York Stock Exchange. The company...
Cardinal Health (NYSE: CAH) is pleased to have been selected by the Ohio Department of Health to support its efforts to distribute COVID-19 vaccines by arranging transportation within the state of...
Read more about Ohio Chooses Cardinal Health for COVID-19 Vaccine Distribution
In response to the COVID-19 pandemic, U.S. oncologists have adjusted patient care by embracing telemedicine and switching more patients to oral therapies to limit office visits—but personally,...
Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership...
Read more about Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2021 revenues of $39.1 billion, an increase of 5% from the first quarter of last year. First quarter GAAP operating loss was...
Read more about Cardinal Health Reports First Quarter Fiscal 2021 Results
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2021 on November 5 prior to the opening of trading on the New York Stock Exchange. The company will...
Cardinal Health (NYSE: CAH) announced today that its board of directors has elected Sheri Edison as an independent director, effective September 1. Ms. Edison joins the board with extensive...
Read more about Sheri Edison to join Cardinal Health Board of Directors
Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2020 revenues of $36.7 billion, a decrease of 2 percent from the fourth quarter last year. GAAP operating earnings were $270...
Read more about Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2020
Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2020 on August 6 prior to the opening of trading on the New York Stock Exchange. The...
Cardinal Health (NYSE: CAH) announced today that its board of directors has elected David C. Evans as an independent director, effective July 1. Mr. Evans brings decades of financial expertise and...
Read more about Dave Evans to join Cardinal Health Board of Directors
Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of the Company's $500 million 4.625% notes due 2020. The early redemption...
Read more about Cardinal Health Announces Redemption of Outstanding Notes
Cardinal Health (NYSE: CAH) today reported financial results for the third quarter of fiscal 2020 ended March 31, 2020.Third quarter revenue was $39.2 billion, an increase of 11% from the third...
Read more about Cardinal Health Reports Third Quarter Results for Fiscal Year 2020
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2020 on May 11 prior to the opening of trading on the New York Stock Exchange. The company will...
Cardinal Health (NYSE: CAH) announced today that its board of directors elected Jason Hollar as Chief Financial Officer, effective May 12. Mr. Hollar most recently served as the chief financial...
Read more about Cardinal Health names Jason Hollar as new Chief Financial Officer
The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4811 per share. The dividend will be payable on April 15, 2020, to shareholders of record at the close...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health (NYSE: CAH) today reported financial results for the second quarter of fiscal 2020 ended December 31, 2019. Second quarter revenue was $39.7 billion, an increase of 5% from the...
Read more about Cardinal Health Reports Second Quarter Results for Fiscal Year 2020
Today, in continued coordination with the U.S. Food and Drug Administration (FDA), Cardinal Health announced it is initiating two voluntary field actions for select Cardinal Health Presource®...
Cardinal Health (NYSE: CAH) plans to release second quarter financial results for its fiscal year 2020 on Feb. 6 prior to the opening of trading on the New York Stock Exchange. The company will...
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2020 revenue of $37.3 billion, an increase of 6 percent from the first quarter last year. First quarter GAAP operating loss was...
Read more about Cardinal Health Reports First Quarter Results for Fiscal Year 2020
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced this morning that they have agreed to a $215 million settlement with two Ohio counties, Cuyahoga and...
Read more about Distributors Reach Settlement With Ohio Counties in Opioids Case
Cardinal Health (NYSE: CAH) plans to release first quarter financial results for its fiscal year 2020 on Nov. 7 prior to the opening of trading on the New York Stock Exchange. The company will...
Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2019 revenues of $37.4 billion, an increase of 6 percent from the fourth quarter last year. GAAP operating earnings were $307...
Read more about Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2019
Cardinal Health (NYSE: CAH) today announced that Dean Scarborough, former Chairman and Chief Executive Officer of Avery Dennison Corporation, and John Weiland, former Vice Chairman, President and...
Read more about Dean Scarborough and John Weiland to Join Cardinal Health's Board of Directors
Cardinal Health (NYSE:CAH) today announced that Stephen Mason, President of the company's Cardinal Health at-Home Solutions business, has been promoted to Chief Executive Officer of Cardinal...
Read more about Cardinal Health Appoints Stephen Mason To Lead Medical Segment
Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2019 on August 8 prior to the opening of trading on the New York Stock Exchange. The...
Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2019 revenues of $35.2 billion, an increase of 5 percent. The company also reported a decrease in GAAP operating earnings of 21...
Read more about Cardinal Health Reports Third Quarter Results for Fiscal Year 2019
To meet the growing needs of the market, Cardinal Health Specialty Solutions has strengthened its cell and gene therapy capability with a coordinated suite of specialty distribution, third-party...
DUBLIN, Ohio, April 22, 2019 — Cardinal Health today announced the acquisition of mscripts®, a company that mscripts®, founded in 2007, was created to provide a digital communication platform...
Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2019 on May 9 prior to the opening of trading on the New York Stock Exchange. The company will...
Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2019 revenues of $37.7 billion, an increase of 7 percent. The company also reported growth in GAAP operating earnings of 26...
Read more about Cardinal Health Reports Second Quarter Results for Fiscal Year 2019
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2019 on February 7 prior to the opening of trading on the New York Stock Exchange. The company...
Cardinal Health (NYSE: CAH) today announced that its board of directors has elected J. Michael Losh as an independent director effective December 5. Losh will serve as the chairman of the Audit...
Read more about Cardinal Health Elects J. Michael Losh to its Board of Directors
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2019 revenues of $35.2 billion, an increase of 8 percent. The company also reported growth in GAAP operating earnings of 211...
Read more about Cardinal Health Reports First Quarter Results for Fiscal Year 2019
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2019 on November 8 prior to the opening of trading on the New York Stock Exchange. The company will...
The inaugural Women Pharmacist Day will be commemorated on Oct. 12, 2018, in conjunction with National Pharmacist Month, to recognize the important contributions women pharmacists make, every day,...
Cardinal Health announced that Ola Snow will become chief human resources officer for the company, following the departure of Pamela Kimmet, who is leaving the...
Read more about Cardinal Health Names Ola Snow as Chief Human Resources Officer
The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to shareholders of record at the close...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health (NYSE: CAH) today reported fourth-quarter fiscal year 2018 revenues of $35 billion, an increase of 7 percent from the fourth quarter last year, and fiscal year 2018 revenues of...
Read more about Cardinal Health Reports Fourth-quarter and Year-end Results for Fiscal Year 2018
Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2018 on August 6 prior to the opening of trading on the New York Stock Exchange. The...
Cardinal Health, Inc. (NYSE: CAH) and Clayton, Dubilier & Rice ("CD&R") announced today that CD&R-managed funds will jointly invest with Cardinal Health in naviHealth, the largest manager of...
The Cardinal Health (NYSE: CAH) board of directors today approved a 3 percent increase in the company's quarterly dividend from $0.4624 per share to $0.4763 per share. The dividend will be payable...
Read more about Cardinal Health Board of Directors Approves Quarterly Dividend